319 related articles for article (PubMed ID: 33122098)
1. HPV post-infection microenvironment and cervical cancer.
Yuan Y; Cai X; Shen F; Ma F
Cancer Lett; 2021 Jan; 497():243-254. PubMed ID: 33122098
[TBL] [Abstract][Full Text] [Related]
2. Biology and pathological associations of the human papillomaviruses: a review.
Cheah PL; Looi LM
Malays J Pathol; 1998 Jun; 20(1):1-10. PubMed ID: 10879257
[TBL] [Abstract][Full Text] [Related]
3. Human Papillomavirus and the Stroma: Bidirectional Crosstalk during the Virus Life Cycle and Carcinogenesis.
Spurgeon ME; Lambert PF
Viruses; 2017 Aug; 9(8):. PubMed ID: 28792475
[TBL] [Abstract][Full Text] [Related]
4. Human papillomaviruses and cervical cancer.
DiMaio D; Liao JB
Adv Virus Res; 2006; 66():125-59. PubMed ID: 16877060
[TBL] [Abstract][Full Text] [Related]
5. An overview of human papillomaviruses and current vaccine strategies.
Gnanamony M; Peedicayil A; Abraham P
Indian J Med Microbiol; 2007 Jan; 25(1):10-7. PubMed ID: 17377346
[TBL] [Abstract][Full Text] [Related]
6. [Escape mechanisms to the innate immune response in HPV-associated cervical cancer].
del Toro-Arreola S; García-Chagollán M; Jave-Suárez LF
Rev Med Inst Mex Seguro Soc; 2015; 53 Suppl 2():S194-9. PubMed ID: 26462516
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group.
Bosch FX; Manos MM; Muñoz N; Sherman M; Jansen AM; Peto J; Schiffman MH; Moreno V; Kurman R; Shah KV
J Natl Cancer Inst; 1995 Jun; 87(11):796-802. PubMed ID: 7791229
[TBL] [Abstract][Full Text] [Related]
8. Persistence of human papillomavirus infection: keys to malignant progression.
Bodily J; Laimins LA
Trends Microbiol; 2011 Jan; 19(1):33-9. PubMed ID: 21050765
[TBL] [Abstract][Full Text] [Related]
9. Increased High-Risk Human Papillomavirus Viral Load Is Associated With Immunosuppressed Microenvironment and Predicts a Worse Long-Term Survival in Cervical Cancer Patients.
Cao M; Wang Y; Wang D; Duan Y; Hong W; Zhang N; Shah W; Wang Y; Chen H
Am J Clin Pathol; 2020 Mar; 153(4):502-512. PubMed ID: 31819948
[TBL] [Abstract][Full Text] [Related]
10. [HPV infection and cervical carcinoma--epidemiology, detection and immunology].
Schneider A; Dürst M; Kaufmann AM
Zentralbl Gynakol; 2001 Apr; 123(4):179-85. PubMed ID: 11370524
[TBL] [Abstract][Full Text] [Related]
11. Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia.
Villa LL; Sichero L; Rahal P; Caballero O; Ferenczy A; Rohan T; Franco EL
J Gen Virol; 2000 Dec; 81(Pt 12):2959-2968. PubMed ID: 11086127
[TBL] [Abstract][Full Text] [Related]
12. Immunopathogenesis of HPV-Associated Cancers and Prospects for Immunotherapy.
Smola S
Viruses; 2017 Sep; 9(9):. PubMed ID: 28895886
[TBL] [Abstract][Full Text] [Related]
13. Immune concept of human papillomaviruses and related antigens in local cancer milieu of human cervical neoplasia.
Sheu BC; Chang WC; Lin HH; Chow SN; Huang SC
J Obstet Gynaecol Res; 2007 Apr; 33(2):103-13. PubMed ID: 17441881
[TBL] [Abstract][Full Text] [Related]
14. [Human papillomavirus and cervical neoplasia].
Rosa MI; Medeiros LR; Rosa DD; Bozzeti MC; Silva FR; Silva BR
Cad Saude Publica; 2009 May; 25(5):953-64. PubMed ID: 19488480
[TBL] [Abstract][Full Text] [Related]
15. APOBEC-mediated genomic alterations link immunity and viral infection during human papillomavirus-driven cervical carcinogenesis.
Chen L; Qiu X; Zhang N; Wang Y; Wang M; Li D; Wang L; Du Y
Biosci Trends; 2017 Sep; 11(4):383-388. PubMed ID: 28717061
[TBL] [Abstract][Full Text] [Related]
16. Immune responses against human papillomavirus (HPV) infection and evasion of host defense in cervical cancer.
Sasagawa T; Takagi H; Makinoda S
J Infect Chemother; 2012 Dec; 18(6):807-15. PubMed ID: 23117294
[TBL] [Abstract][Full Text] [Related]
17. Chapter 4: Genital tract infections, cervical inflammation, and antioxidant nutrients--assessing their roles as human papillomavirus cofactors.
Castle PE; Giuliano AR
J Natl Cancer Inst Monogr; 2003; (31):29-34. PubMed ID: 12807942
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus infection and cervical cancer in Brazil: a retrospective study.
Cavalcanti SM; Deus FC; Zardo LG; Frugulhetti IC; Oliveira LH
Mem Inst Oswaldo Cruz; 1996; 91(4):433-40. PubMed ID: 9070405
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia.
Bosch FX; Burchell AN; Schiffman M; Giuliano AR; de Sanjose S; Bruni L; Tortolero-Luna G; Kjaer SK; Muñoz N
Vaccine; 2008 Aug; 26 Suppl 10():K1-16. PubMed ID: 18847553
[TBL] [Abstract][Full Text] [Related]
20. Correlation of CXCL12 expression and FoxP3+ cell infiltration with human papillomavirus infection and clinicopathological progression of cervical cancer.
Jaafar F; Righi E; Lindstrom V; Linton C; Nohadani M; Van Noorden S; Lloyd T; Poznansky J; Stamp G; Dina R; Coleman DV; Poznansky MC
Am J Pathol; 2009 Oct; 175(4):1525-35. PubMed ID: 19808652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
